IBDEI06J ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,2534,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2534,1,3,0)
 ;;=3^Primary biliary cirrhosis
 ;;^UTILITY(U,$J,358.3,2534,1,4,0)
 ;;=4^K74.3
 ;;^UTILITY(U,$J,358.3,2534,2)
 ;;=^5008819
 ;;^UTILITY(U,$J,358.3,2535,0)
 ;;=K74.4^^6^75^48
 ;;^UTILITY(U,$J,358.3,2535,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2535,1,3,0)
 ;;=3^Secondary biliary cirrhosis
 ;;^UTILITY(U,$J,358.3,2535,1,4,0)
 ;;=4^K74.4
 ;;^UTILITY(U,$J,358.3,2535,2)
 ;;=^5008820
 ;;^UTILITY(U,$J,358.3,2536,0)
 ;;=K92.1^^6^75^43
 ;;^UTILITY(U,$J,358.3,2536,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2536,1,3,0)
 ;;=3^Melena
 ;;^UTILITY(U,$J,358.3,2536,1,4,0)
 ;;=4^K92.1
 ;;^UTILITY(U,$J,358.3,2536,2)
 ;;=^5008914
 ;;^UTILITY(U,$J,358.3,2537,0)
 ;;=K92.2^^6^75^34
 ;;^UTILITY(U,$J,358.3,2537,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2537,1,3,0)
 ;;=3^Gastrointestinal hemorrhage, unspecified
 ;;^UTILITY(U,$J,358.3,2537,1,4,0)
 ;;=4^K92.2
 ;;^UTILITY(U,$J,358.3,2537,2)
 ;;=^5008915
 ;;^UTILITY(U,$J,358.3,2538,0)
 ;;=K90.1^^6^75^49
 ;;^UTILITY(U,$J,358.3,2538,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2538,1,3,0)
 ;;=3^Tropical sprue
 ;;^UTILITY(U,$J,358.3,2538,1,4,0)
 ;;=4^K90.1
 ;;^UTILITY(U,$J,358.3,2538,2)
 ;;=^5008894
 ;;^UTILITY(U,$J,358.3,2539,0)
 ;;=K90.9^^6^75^39
 ;;^UTILITY(U,$J,358.3,2539,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2539,1,3,0)
 ;;=3^Intestinal malabsorption, unspecified
 ;;^UTILITY(U,$J,358.3,2539,1,4,0)
 ;;=4^K90.9
 ;;^UTILITY(U,$J,358.3,2539,2)
 ;;=^5008899
 ;;^UTILITY(U,$J,358.3,2540,0)
 ;;=K52.2^^6^75^2
 ;;^UTILITY(U,$J,358.3,2540,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2540,1,3,0)
 ;;=3^Allergic and dietetic gastroenteritis and colitis
 ;;^UTILITY(U,$J,358.3,2540,1,4,0)
 ;;=4^K52.2
 ;;^UTILITY(U,$J,358.3,2540,2)
 ;;=^5008701
 ;;^UTILITY(U,$J,358.3,2541,0)
 ;;=K52.89^^6^75^44
 ;;^UTILITY(U,$J,358.3,2541,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2541,1,3,0)
 ;;=3^Noninfective gastroenteritis and colitis NEC
 ;;^UTILITY(U,$J,358.3,2541,1,4,0)
 ;;=4^K52.89
 ;;^UTILITY(U,$J,358.3,2541,2)
 ;;=^5008703
 ;;^UTILITY(U,$J,358.3,2542,0)
 ;;=K64.9^^6^75^37
 ;;^UTILITY(U,$J,358.3,2542,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2542,1,3,0)
 ;;=3^Hemorrhoids,Unspec
 ;;^UTILITY(U,$J,358.3,2542,1,4,0)
 ;;=4^K64.9
 ;;^UTILITY(U,$J,358.3,2542,2)
 ;;=^5008775
 ;;^UTILITY(U,$J,358.3,2543,0)
 ;;=B18.1^^6^76^10
 ;;^UTILITY(U,$J,358.3,2543,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2543,1,3,0)
 ;;=3^Chronic viral hepatitis B without delta-agent
 ;;^UTILITY(U,$J,358.3,2543,1,4,0)
 ;;=4^B18.1
 ;;^UTILITY(U,$J,358.3,2543,2)
 ;;=^5000547
 ;;^UTILITY(U,$J,358.3,2544,0)
 ;;=B18.2^^6^76^11
 ;;^UTILITY(U,$J,358.3,2544,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2544,1,3,0)
 ;;=3^Chronic viral hepatitis C
 ;;^UTILITY(U,$J,358.3,2544,1,4,0)
 ;;=4^B18.2
 ;;^UTILITY(U,$J,358.3,2544,2)
 ;;=^5000548
 ;;^UTILITY(U,$J,358.3,2545,0)
 ;;=K73.9^^6^76^9
 ;;^UTILITY(U,$J,358.3,2545,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2545,1,3,0)
 ;;=3^Chronic hepatitis, unspecified
 ;;^UTILITY(U,$J,358.3,2545,1,4,0)
 ;;=4^K73.9
 ;;^UTILITY(U,$J,358.3,2545,2)
 ;;=^5008815
 ;;^UTILITY(U,$J,358.3,2546,0)
 ;;=K76.0^^6^76^14
 ;;^UTILITY(U,$J,358.3,2546,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2546,1,3,0)
 ;;=3^Fatty (change of) liver, not elsewhere classified
 ;;^UTILITY(U,$J,358.3,2546,1,4,0)
 ;;=4^K76.0
 ;;^UTILITY(U,$J,358.3,2546,2)
 ;;=^5008831
 ;;^UTILITY(U,$J,358.3,2547,0)
 ;;=K75.81^^6^76^19
 ;;^UTILITY(U,$J,358.3,2547,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2547,1,3,0)
 ;;=3^Nonalcoholic steatohepatitis (NASH)
 ;;
 ;;$END ROU IBDEI06J
